Bayer, Janssen Win 2nd Xarelto Bellwether Trial

Law360, New York (June 12, 2017, 5:47 PM EDT) -- A New Orleans federal jury on Monday awarded a defense verdict to Janssen and Bayer in the second bellwether trial in multidistrict litigation over unstoppable bleeding allegedly caused by their blood thinner Xarelto.

It was the second win for the drug companies in the 15,000-case litigation. The verdict came just hours after the end of closing arguments in New Orleans on Monday.

In the case, widower Joseph Orr said that the companies failed to warn doctors of Xarelto's dangers, and therefore were responsible for the stroke that killed his wife Sharyn Orr in May 2015.

Janssen Pharmaceuticals Inc. in a statement...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!